Clinical Data to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference.NEWTON, Mass. -- Clinical Data, Inc. (NASDAQ NASDAQin full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CLDA CLDA California Lyme Disease Association ) announced today that Drew Fromkin, Executive Vice President and Chief Marketing Officer of Clinical Data, will present on behalf of the company at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference on Tuesday, November 8, 2005 at 8:20 am, Eastern, in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . About Clinical Data, Inc. Clinical Data, Inc. is a worldwide leader in developing and commercializing pharmacogenomics Pharmacogenomics is the branch of pharmacology which deals with the influence of genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with a drug's efficacy or toxicity. and clinical diagnostics to improve patient care. The company's genomic services are marketed to the pharmaceutical, biotech, diagnostic, academic and agricultural marketplaces. The company is utilizing pharmacogenomics to develop molecular diagnostics and more efficacious ef·fi·ca·cious adj. Producing or capable of producing a desired effect. See Synonyms at effective. [From Latin effic therapeutics by finding genetic markers to guide drug development and utilization. Its diagnostic and instrumentation business has a market focus on the physician office, hospital and small to medium sized laboratory segments. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion